Bacillus Variant Screening for Ultra-High-Molecular-Weight γ-PGA Production

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods struggle to produce ultra-high-molecular-weight γ-polyglutamic acid (γ-PGA) with an average molecular weight of 20 million or more, and there is a lack of effective screening methods for variant strains of Bacillus bacteria capable of producing such high-molecular-weight γ-PGA.

Innovation Solution

A screening method involving the culture of Bacillus bacteria expressing PgsBCA and PgdS, followed by colony selection based on luster formation, identifies variant strains with mutations in the PgsA amino acid sequence, enabling the production of ultra-high-molecular-weight γ-PGA.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If PgdS is overexpressed to degrade γ-DL-PGA, then molecular weight control is improved, but γ-PGA production is reduced due to colony luster loss

Engineering Contradiction:
Improvemolecular weight controlVSAvoidγ-PGA production
Core Design Contradiction:
Manufacturing precisionVSQuantity of substance

Solution Approach 1:

The invention changes the chemical composition parameter of γ-PGA from a mixture of L and D glutamic acid residues (γ-DL-PGA) to predominantly L glutamic acid residues (γ-L-PGA) through selective degradation by PgdS. This parameter change allows the degraded polymer to maintain colony luster while achieving desired molecular weight control, resolving the contradiction between precision and quantity.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention converts the harmful effect of PgdS-mediated degradation (colony luster loss and reduced γ-PGA production) into a beneficial outcome by selecting for mutant strains that produce γ-L-PGA. The degradation process that initially appears harmful actually enables the selection of superior strains producing ultra-high molecular weight γ-L-PGA with maintained colony characteristics.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Quantity of substance

If conventional screening methods are used, then general γ-PGA production is achieved, but ultra-high molecular weight γ-L-PGA production is not obtained

Engineering Contradiction:
Improveγ-PGA productionVSAvoidmolecular weight and composition control
Core Design Contradiction:
Quantity of substanceVSManufacturing precision

Solution Approach 1:

The invention introduces a feedback mechanism where colony luster serves as a visual indicator for selecting mutant strains. Strains producing γ-L-PGA maintain colony luster despite PgdS expression, providing immediate feedback for identifying superior mutants. This feedback loop enables systematic screening and selection of strains producing ultra-high molecular weight γ-L-PGA, resolving the contradiction between quantity and precision.

Inventive Principle:
Principle #23Feedback

3Device complexity

If PgsA is deleted to simplify the system, then γ-PGA production is maintained, but ultra-high molecular weight γ-L-PGA production is not achieved

Engineering Contradiction:
Improvegene expression systemVSAvoidmolecular weight and composition control
Core Design Contradiction:
Device complexityVSManufacturing precision

Solution Approach 1:

The invention changes the compositional parameter of γ-PGA from mixed L/D glutamic acid residues to predominantly L glutamic acid residues by maintaining PgsA expression while introducing mutations that enable selective production. This parameter change allows the simplified system to achieve ultra-high molecular weight γ-L-PGA production, resolving the contradiction between device complexity and manufacturing precision.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method successfully produces γ-PGA with an average molecular weight of 20 million or more, specifically γ-L-PGA, through the identification and cultivation of variant Bacillus strains with specific mutations, overcoming the limitations of previous methods.

Implementation Method 1

PgdS, which has the function of cleaving the bond between D-glutamic acid and L-glutamic acid, or between L-glutamic acid and L-glutamic acid

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

γ-PGA is known to be produced by PgsBCAE, which is a γ-PGA synthetase complex composed of four proteins: PgsB, PgsC, PgsA, and PgsE

Methodology Applied
Scientific EffectPolymerization:

Data Source

PatentEP4600343A1Super-high-molecular gamma-polyglutamic acid, bacillus genus bacterium variant strain that produces said polyglutamic acid, and method for screening for said bacillus genus bacterium variant strain
Publication Date: 2025.08.13 KOBE UNIV
  • EP4600343A1 patent drawingFigure 1
  • EP4600343A1 patent drawingFigure 2
  • EP4600343A1 patent drawingFigure 3

AI summary

Provided is ultra-high-molecular-weight γ-polyglutamic acid with an average molecular weight of 20 million or more. Provided is a variant strain of Bacillus bacteria capable of producing the ultra-high-molecular-weight γ-PGA. Provided is a screening method for a variant strain of Bacillus bacteria capable of producing the ultra-high-molecular-weight γ-PGA. A variant strain of Bacillus bacteria is produced and allowed to produce γ-polyglutamic acid with an average molecular weight of 20 million or more.